Notice of Teleconference of the Chronic Hazard Advisory Panel on Phthalates and Phthalate Substitutes, 57024-57025 [2011-23645]

Download as PDF 57024 Federal Register / Vol. 76, No. 179 / Thursday, September 15, 2011 / Notices Conference call. Public access is available at: NOAA, SSMC 3, Room 11836, 1315 East-West Highway, Silver Spring, Md. Status: The meeting will be open to public participation with a 5-minute public comment period from 5:05–5:10 p.m. The SAB expects that public statements presented at its meetings will not be repetitive of previously submitted verbal or written statements. In general, each individual or group making a verbal presentation will be limited to a total time of one minute. Written comments should be received in the SAB Executive Director’s Office by September 26, 2011 to provide sufficient time for SAB review. Written comments received by the SAB Executive Director after September 26, 2011, will be distributed to the SAB, but may not be reviewed prior to the meeting date. ADDRESSES: The Science Advisory Board (SAB) was established by a Decision Memorandum dated September 25, 1997, and is the only Federal Advisory Committee with responsibility to advise the Under Secretary of Commerce for Oceans and Atmosphere on strategies for research, education, and application of science to operations and information services. SAB activities and advice provide necessary input to ensure that National Oceanic and Atmospheric Administration (NOAA) science programs are of the highest quality and provide optimal support to resource management. Matters To Be Considered: The meeting will include the following topics: (1) Final Report from the Climate and Environmental Information Services Working Groups’ Climate Partnership Task Force (2) Review of new members and renewal of member terms for the Environmental Information Services Working Group (3) Terms of Reference and Proposed Members for a Satellite Task Force (4) NOAA Request for SAB Review of the NOAA Research Enterprise and (5) NOAA Request for the Ecosystem Sciences and Management Working Group to vet reviewers for the National Marine Fisheries Science Centers. For the latest agenda, please visit the SAB Web site at https://www.sab.noaa.gov. wreier-aviles on DSKGBLS3C1PROD with NOTICES SUPPLEMENTARY INFORMATION: Dr. Cynthia Decker, Executive Director, Science Advisory Board, NOAA, Rm. 11230, 1315 East-West Highway, Silver Spring, Maryland 20910. (Phone: 301– 734–1156, Fax: 301–713–1459, E-mail: Cynthia.Decker@noaa.gov). FOR FURTHER INFORMATION CONTACT: VerDate Mar<15>2010 15:07 Sep 14, 2011 Jkt 223001 Dated: September 8, 2011. Mark E. Brown, Chief Financial Officer/Chief Administrative Officer, Office of Oceanic and Atmospheric Research, National Oceanic and Atmospheric Administration. [FR Doc. 2011–23675 Filed 9–14–11; 8:45 am] BILLING CODE 3510–KD–P CONSUMER PRODUCT SAFETY COMMISSION Notice of Teleconference of the Chronic Hazard Advisory Panel on Phthalates and Phthalate Substitutes Consumer Product Safety Commission. ACTION: Notice of meeting. AGENCY: The U.S. Consumer Product Safety Commission (‘‘CPSC’’ or ‘‘Commission’’) is announcing a teleconference of the Chronic Hazard Advisory Panel (CHAP) on phthalates and phthalate substitutes. The Commission appointed this CHAP to study the effects on children’s health of all phthalates and phthalate alternatives as used in children’s toys and child care articles, pursuant to section 108 of the Consumer Product Safety Improvement Act of 2008 (CPSIA) (Pub. L. 110–314). The CHAP will discuss its progress toward completing its analysis of potential risks from phthalates and phthalate substitutes. DATES: The teleconference will take place from 11:30 a.m. to 1 p.m. E.D.T. (4:30 p.m. to 6 p.m. British Summer Time or 15:30 to 17:00 G.M.T.) on Tuesday, September 20, 2011. Interested members of the public may listen to the CHAP’s discussion. Members of the public will not have the opportunity to ask questions, comment, or otherwise participate in the teleconference. Interested parties should contact the CPSC project manager, Michael Babich, by e-mail (mbabich@cpsc.gov) for call-in instructions no later than Friday, September 16, 2011. FOR FURTHER INFORMATION CONTACT: To request access to the teleconference, contact the project manager by e-mail at mbabich@cpsc.gov, no later than Friday, September 16, 2011. For all other questions, contact: Michael Babich, Directorate for Health Sciences, Consumer Product Safety Commission, Bethesda, MD 20814; telephone (301) 504–7253; e-mail mbabich@cpsc.gov. SUPPLEMENTARY INFORMATION: Section 108 of the CPSIA permanently prohibits the sale of any ‘‘children’s toy or child care article’’ containing more than 0.1 percent of each of three specified phthalates: Di- (2-ethylhexyl) phthalate SUMMARY: PO 00000 Frm 00008 Fmt 4703 Sfmt 4703 (DEHP), dibutyl phthalate (DBP), and benzyl butyl phthalate (BBP). Section 108 of the CPSIA also prohibits, on an interim basis, the sale of any ‘‘children’s toy that can be placed in a child’s mouth’’ or ‘‘child care article’’ containing more than 0.1 percent of each of three additional phthalates: diisononyl phthalate (DINP), diisodecyl phthalate (DIDP), and di-n-octyl phthalate (DnOP). Moreover, section 108 of the CPSIA requires the Commission to convene a CHAP ‘‘to study the effects on children’s health of all phthalates and phthalate alternatives as used in children’s toys and child care articles.’’ The CPSIA requires the CHAP to complete an examination of the full range of phthalates that are used in products for children and: • Examine all of the potential health effects (including endocrine disrupting effects) of the full range of phthalates; • Consider the potential health effects of each of these phthalates, both in isolation and in combination with other phthalates; • Examine the likely levels of children’s, pregnant women’s, and others’ exposure to phthalates, based on a reasonable estimation of normal and foreseeable use and abuse of such products; • Consider the cumulative effect of total exposure to phthalates, both from children’s products and from other sources, such as personal care products; • Review all relevant data, including the most recent, best available, peerreviewed, scientific studies of these phthalates and phthalate alternatives that employ objective data collection practices or employ other objective methods; • Consider the health effects of phthalates, not only from ingestion, but also as a result of dermal, hand-tomouth, or other exposure; • Consider the level at which there is a reasonable certainty of no harm to children, pregnant women, or other susceptible individuals and their offspring, reviewing the best available science, and using sufficient safety factors to account for uncertainties regarding exposure and susceptibility of children, pregnant women, and other potentially susceptible individuals; and • Consider possible similar health effects of phthalate alternatives used in children’s toys and child care articles. The CPSIA contemplates completion of the CHAP’s examination within 18 months of the panel’s appointment. The CHAP must review prior work on phthalates by the Commission, but it is not to be considered determinative E:\FR\FM\15SEN1.SGM 15SEN1 Federal Register / Vol. 76, No. 179 / Thursday, September 15, 2011 / Notices because the CHAP’s examination must be conducted de novo. The CHAP must make recommendations to the Commission about which phthalates, or combinations of phthalates (in addition to those identified in section 108 of the CPSIA), or phthalate alternatives should be prohibited from use in children’s toys or child care articles or otherwise restricted. The Commission selected the CHAP members from scientists nominated by the National Academy of Sciences. See 15 U.S.C. 2077, 2030(b). The CHAP met previously in April, July, and December 2010, and in March and July 2011, at the CPSC’s offices in Bethesda, MD, and by teleconference in November 2010. The CHAP heard testimony from interested parties at the July 2010 meeting. The September 2011 conference call will include discussion of the CHAP’s progress in its analysis of potential risks from phthalates and phthalate substitutes. There will not be any opportunity for public comment during the conference call. Dated: September 12, 2011. Todd A. Stevenson, Secretary, Consumer Product Safety Commission. [FR Doc. 2011–23645 Filed 9–14–11; 8:45 am] BILLING CODE 6355–01–P Dated: September 13, 2011. Todd A. Stevenson, Secretary. [FR Doc. 2011–23808 Filed 9–13–11; 4:15 pm] BILLING CODE 6355–01–P CONSUMER PRODUCT SAFETY COMMISSION Sunshine Act Meeting Notice Wednesday, September 21, 2011; 2–3 p.m. PLACE: Hearing Room 420, Bethesda Towers, 4330 East West Highway, Bethesda, Maryland. STATUS: Closed to the public. MATTER TO BE CONSIDERED: TIME AND DATE: Compliance Status Report The Commission staff will brief the Commission on the status of compliance matters. For a recorded message containing the latest agenda information, call (301) 504–7948. CONTACT PERSON FOR MORE INFORMATION: Todd A. Stevenson, Office of the Secretary, U.S. Consumer Product Safety Commission, 4330 East West Highway, Bethesda, MD 20814, (301) 504–7923. Dated: September 13, 2011. Todd A. Stevenson, Secretary. CONSUMER PRODUCT SAFETY COMMISSION [FR Doc. 2011–23809 Filed 9–13–11; 4:15 pm] BILLING CODE 6355–01–P Sunshine Act Meeting Notice TIME AND DATE: Wednesday, September 21, 2011, 9 a.m.–12 p.m. CORPORATION FOR NATIONAL AND COMMUNITY SERVICE Room 420, Bethesda Towers, 4330 East West Highway, Bethesda, Maryland. Proposed Information Collection; Comment Request PLACE: Commission Meeting—Open to the Public. STATUS: wreier-aviles on DSKGBLS3C1PROD with NOTICES MATTERS TO BE CONSIDERED: Decisional Matter: Unblockable Drains. Briefing Matter: Table Saws— Advance Notice of Proposed Rulemaking. A live Webcast of the meeting can be viewed at https://www.cpsc.gov/webcast. For a recorded message containing the latest agenda information, call (301) 504–7948. CONTACT PERSON FOR MORE INFORMATION: Todd A. Stevenson, Office of the Secretary, U.S. Consumer Product Safety Commission, 4330 East West Highway, Bethesda, MD 20814, (301) 504–7923. VerDate Mar<15>2010 15:07 Sep 14, 2011 Jkt 223001 Corporation for National and Community Service. ACTION: Notice. AGENCY: The Corporation for National and Community Service (hereinafter the ‘‘Corporation’’), as part of its continuing effort to reduce paperwork and respondent burden, conducts a preclearance consultation program to provide the general public and federal agencies with an opportunity to comment on proposed and/or continuing collections of information in accordance with the Paperwork Reduction Act of 1995 (PRA95) (44 U.S.C. 3506(c)(2)(A)). This program helps to ensure that requested data can be provided in the desired format, reporting burden (time and financial resources) is minimized, collection instruments are clearly understood, and SUMMARY: PO 00000 Frm 00009 Fmt 4703 Sfmt 4703 57025 the impact of collection requirement on respondents can be properly assessed. Individuals who use a telecommunications device for the deaf (TTY–TDD) may call (202) 565–2799 between 8:30 a.m. and 5 p.m. eastern time, Monday through Friday. Currently, the Corporation is soliciting comments concerning AmeriCorps Application Instructions: State Commissions; State and National Competitive; Professional Corps; Indian Tribes; States and Territories without Commissions; and State and National Planning. Applicants will respond to the questions included in this ICR in order to apply for funding through these grant competitions. Copies of the information collection request can be obtained by contacting the office listed in the ADDRESSES section of this notice. DATES: Written comments must be submitted to the individual and office listed in the ADDRESSES section by November 14, 2011. ADDRESSES: You may submit comments, identified by the title of the information collection activity, by any of the following methods: (1) By mail sent to: Corporation for National and Community Service; Attention: Amy Borgstrom, Associate Director for Policy, Room 9515; 1201 New York Avenue, NW., Washington, DC 20525. (2) By hand delivery or by courier to the Corporation’s mailroom at Room 8100 at the mail address given in paragraph (1) above, between 9 a.m. and 4 p.m. Monday through Friday, except Federal holidays. (3) By fax to: (202) 606–3476, Attention: Amy Borgstrom, Associate Director for Policy. (4) Electronically through the Corporation’s e-mail address system: aborgstrom@cns.gov. FOR FURTHER INFORMATION CONTACT: Amy Borgstrom, (202) 606–6930, or by e-mail at aborgstrom@cns.gov. SUPPLEMENTARY INFORMATION: The Corporation is particularly interested in comments that: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Corporation, including whether the information will have practical utility; • Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and E:\FR\FM\15SEN1.SGM 15SEN1

Agencies

[Federal Register Volume 76, Number 179 (Thursday, September 15, 2011)]
[Notices]
[Pages 57024-57025]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-23645]


=======================================================================
-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION


Notice of Teleconference of the Chronic Hazard Advisory Panel on 
Phthalates and Phthalate Substitutes

AGENCY: Consumer Product Safety Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Consumer Product Safety Commission (``CPSC'' or 
``Commission'') is announcing a teleconference of the Chronic Hazard 
Advisory Panel (CHAP) on phthalates and phthalate substitutes. The 
Commission appointed this CHAP to study the effects on children's 
health of all phthalates and phthalate alternatives as used in 
children's toys and child care articles, pursuant to section 108 of the 
Consumer Product Safety Improvement Act of 2008 (CPSIA) (Pub. L. 110-
314). The CHAP will discuss its progress toward completing its analysis 
of potential risks from phthalates and phthalate substitutes.

DATES: The teleconference will take place from 11:30 a.m. to 1 p.m. 
E.D.T. (4:30 p.m. to 6 p.m. British Summer Time or 15:30 to 17:00 
G.M.T.) on Tuesday, September 20, 2011. Interested members of the 
public may listen to the CHAP's discussion. Members of the public will 
not have the opportunity to ask questions, comment, or otherwise 
participate in the teleconference. Interested parties should contact 
the CPSC project manager, Michael Babich, by e-mail (mbabich@cpsc.gov) 
for call-in instructions no later than Friday, September 16, 2011.

FOR FURTHER INFORMATION CONTACT: To request access to the 
teleconference, contact the project manager by e-mail at 
mbabich@cpsc.gov, no later than Friday, September 16, 2011. For all 
other questions, contact: Michael Babich, Directorate for Health 
Sciences, Consumer Product Safety Commission, Bethesda, MD 20814; 
telephone (301) 504-7253; e-mail mbabich@cpsc.gov.

SUPPLEMENTARY INFORMATION: Section 108 of the CPSIA permanently 
prohibits the sale of any ``children's toy or child care article'' 
containing more than 0.1 percent of each of three specified phthalates: 
Di- (2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), and 
benzyl butyl phthalate (BBP). Section 108 of the CPSIA also prohibits, 
on an interim basis, the sale of any ``children's toy that can be 
placed in a child's mouth'' or ``child care article'' containing more 
than 0.1 percent of each of three additional phthalates: diisononyl 
phthalate (DINP), diisodecyl phthalate (DIDP), and di-n-octyl phthalate 
(DnOP).
    Moreover, section 108 of the CPSIA requires the Commission to 
convene a CHAP ``to study the effects on children's health of all 
phthalates and phthalate alternatives as used in children's toys and 
child care articles.'' The CPSIA requires the CHAP to complete an 
examination of the full range of phthalates that are used in products 
for children and:
     Examine all of the potential health effects (including 
endocrine disrupting effects) of the full range of phthalates;
     Consider the potential health effects of each of these 
phthalates, both in isolation and in combination with other phthalates;
     Examine the likely levels of children's, pregnant women's, 
and others' exposure to phthalates, based on a reasonable estimation of 
normal and foreseeable use and abuse of such products;
     Consider the cumulative effect of total exposure to 
phthalates, both from children's products and from other sources, such 
as personal care products;
     Review all relevant data, including the most recent, best 
available, peer-reviewed, scientific studies of these phthalates and 
phthalate alternatives that employ objective data collection practices 
or employ other objective methods;
     Consider the health effects of phthalates, not only from 
ingestion, but also as a result of dermal, hand-to-mouth, or other 
exposure;
     Consider the level at which there is a reasonable 
certainty of no harm to children, pregnant women, or other susceptible 
individuals and their offspring, reviewing the best available science, 
and using sufficient safety factors to account for uncertainties 
regarding exposure and susceptibility of children, pregnant women, and 
other potentially susceptible individuals; and
     Consider possible similar health effects of phthalate 
alternatives used in children's toys and child care articles.
    The CPSIA contemplates completion of the CHAP's examination within 
18 months of the panel's appointment. The CHAP must review prior work 
on phthalates by the Commission, but it is not to be considered 
determinative

[[Page 57025]]

because the CHAP's examination must be conducted de novo.
    The CHAP must make recommendations to the Commission about which 
phthalates, or combinations of phthalates (in addition to those 
identified in section 108 of the CPSIA), or phthalate alternatives 
should be prohibited from use in children's toys or child care articles 
or otherwise restricted. The Commission selected the CHAP members from 
scientists nominated by the National Academy of Sciences. See 15 U.S.C. 
2077, 2030(b).
    The CHAP met previously in April, July, and December 2010, and in 
March and July 2011, at the CPSC's offices in Bethesda, MD, and by 
teleconference in November 2010. The CHAP heard testimony from 
interested parties at the July 2010 meeting. The September 2011 
conference call will include discussion of the CHAP's progress in its 
analysis of potential risks from phthalates and phthalate substitutes. 
There will not be any opportunity for public comment during the 
conference call.

    Dated: September 12, 2011.
Todd A. Stevenson,
Secretary, Consumer Product Safety Commission.
[FR Doc. 2011-23645 Filed 9-14-11; 8:45 am]
BILLING CODE 6355-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.